Search Within

David H Ilson

  1. "Biostatistics Service"
Formats
  1. Journal Article (43)
  2. Meeting Abstract (42)
  3. Miscellaneous (1)
Groups
  1. Biostatistics Service (86)
  2. Department of Medicine (86)
  3. Epidemiology and Biostatistics (86)
  4. Gastrointestinal Oncology Service (86)
  5. Solid Tumor Oncology Division (86)
  6. Center for Pancreatic Cancer Research (82)

More Groups

People
  1. Marinela Capanu (65)
  2. Yelena Janjigian (60)
  3. Geoffrey Ku (56)
  4. David Kelsen (53)
  5. Joanne Chou (36)
  6. Laura Tang (28)

More People

Years
  1. 2025 (1)
  2. 2024 (1)
  3. 2023 (10)
  4. 2022 (6)
  5. 2021 (6)
  6. 2020 (4)

More Years

Publications
  1. Journal of Clinical Oncology (45)
  2. Annals of Surgical Oncology (5)
  3. Annals of Surgery (4)
  4. Cancer (4)
  5. Clinical Cancer Research (3)
  6. JAMA Network Open (3)

More Publications

Publishers
  1. American Society of Clinical Oncology (45)
  2. Springer (9)
  3. American Association for Cancer Research (6)
  4. Lippincott Williams & Wilkins (5)
  5. Oxford University Press (5)
  6. Wiley Blackwell (4)

More Publishers

Results (86)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Preoperative chemotherapy plus bevacizumab with early salvage therapy based on FDG-PET response in locally advanced gastroesophageal junction and gastric adenocarcinoma
    Meeting Abstract

    Ku, G. Y.; Kelsen, D. P.; Strong, V. E.; Schòˆder, H.; Janjigian, Y. Y.; Shah, M. A.; Coit, D. G.; Brennan, M. F.; Capanu, M.; Ilson, D. H.
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • A phase II study of afatinib in patients (pts) with metastatic human epidermal growth factor receptor (HER2)-positive trastuzumab-refractory esophagogastric (EG) cancer
    Meeting Abstract

    Janjigian, Y. Y.; Capanu, M.; Gromisch, C. M.; Kelsen, D. P.; Ku, G. Y.; Brown, K. T.; Schattner, M.; Ilson, D. H.; Solit, D. B.; Berger, M. F.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Phase II trial of bevacizumab, irinotecan, cisplatin, and radiation as preoperative therapy in esophageal adenocarcinoma
    Meeting Abstract

    Ilson, D.; Goodman, K. A.; Janjigian, Y. Y.; Shah, M. A.; Kelsen, D. P.; Rizk, N. P.; Rusch, V. W.; Wu, A. J. C.; Campbell, J.; Capanu, M.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Phase II trial of bevacizumab, irinotecan, cisplatin, and radiation as preoperative therapy in esophageal adenocarcinoma
    Meeting Abstract

    Ilson, D.; Goodman, K. A.; Janjigian, Y. Y.; Shah, M. A.; Kelsen, D. P.; Rizk, N. P.; Rusch, V. W.; Wu, A. J. C.; Campbell, J.; Capanu, M.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Phase 2 trial of induction and concurrent chemoradiotherapy with weekly irinotecan and cisplatin followed by surgery for esophageal cancer
    Journal Article

    Ilson, D. H.; Minsky, B. D.; Ku, G. Y.; Rusch, V.; Rizk, N.; Shah, M.; Kelsen, D. P.; Capanu, M.; Tang, L.; Campbell, J.; more...
    Cancer (2012)

    Fulltext@MSK | Save
  • Phase II trial of sorafenib in esophageal (E) and gastroesophageal junction (GEJ) cancer: Response and protracted stable disease observed in adenocarcinoma
    Meeting Abstract

    Ilson, D.; Janjigian, Y. Y.; Shah, M. A.; Kelsen, D. P.; Tang, L. H.; Campbell, J.; Fuqua, L.; Capanu, M.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • A multicenter, phase II study of bortezomib (PS-341) in patients with unresectable or metastatic gastric and gastroesophageal junction adenocarcinoma
    Journal Article

    Shah, M. A.; Power, D. G.; Kindler, H. L.; Holen, K. D.; Kemeny, M. M.; Ilson, D. H.; Tang, L.; Capanu, M.; Wright, J. J.; Kelsen, D. P.
    Investigational New Drugs (2011)

    Fulltext@MSK | Save
  • Phase II study of modified docetaxel, cisplatin, and fluorouracil with bevacizumab in patients with metastatic gastroesophageal adenocarcinoma
    Journal Article

    Shah, M. A.; Jhawer, M.; Ilson, D. H.; Lefkowitz, R. A.; Robinson, E.; Capanu, M.; Kelsen, D. P.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • A phase 2 trial of erlotinib in patients with previously treated squamous cell and adenocarcinoma of the esophagus
    Journal Article

    Ilson, D. H.; Kelsen, D.; Shah, M.; Schwartz, G.; Levine, D. A.; Boyd, J.; Capanu, M.; Miron, B.; Klimstra, D.
    Cancer (2011)

    Fulltext@MSK | Save
  • Recurrence and survival after pathologic complete response to preoperative therapy followed by surgery for gastric or gastrooesophageal adenocarcinoma
    Journal Article

    Fields, R. C.; Strong, V. E.; Gonen, M.; Goodman, K. A.; Rizk, N. P.; Kelsen, D. P.; Ilson, D. H.; Tang, L. H.; Brennan, M. F.; Coit, D. G.; more...
    British Journal of Cancer (2011)

    Fulltext@MSK | Save